Stock Overview
Unjha Formulations Share Price

Unjha Formulations Share Price

27.5
-0.05 (-0.18%)
17 Aug, 2026 • 03:30 PM
BSE: 531762 | Pharmaceuticals | Small Cap

Unjha Formulations Annualised Returns

1 Year

9.40%Increase

3 Years

29.26%Increase

5 Years

22.17%Increase

10 Years

13.14%Increase

Unjha Formulations Share Price Today


As of 17 Aug 2026, Unjha Formulations share price is ₹27.5. The stock opened at ₹28 and had closed at ₹27.6 the previous day. During today’s trading session, Unjha Formulations share price moved between ₹26.21 and ₹28.00, with an average price for the day of ₹27.11. Over the last 52 weeks, the stock has recorded a low of ₹17.52 and a high of ₹29.50. In terms of performance, Unjha Formulations share price has increased by 17.6% over the past six months and has increased by 9.40% over the last year.

Unjha Formulations Stock Performance

1W Return1.29%
1M Return3.77%
6M Return22.17%
1Y Return9.13%
3Y Return128.79%
Today's High₹28
Today's Low₹26.21
52-Week High₹29.5
52-Week Low₹17.52
Prev. Close₹27.55
Open₹28.00
Face Value₹10
Mkt Cap (Cr.)₹12
PE Ratio26.24

Unjha Formulations Share Price Chart

Unjha Formulations Company background

Founded in: 1994
Managing director: Krutiben M Patel
Unjha Formulations Limited was established in June, 1987 as a Partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The companys products are classified under two divisions human consumption and veterinary products. Company launched four new products viz.Bericof, ProtobalNT, Formentin Tablets and Nalizole in the year 199798. The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 199798. During 200203, the Company made manufacturing agreement with Nicholas Piramal India Limited for sale of Isabgol Husk based product TYBOGEL and Morepen Laboratories Ltd. for sale of Dr.Mopren Sat Isabgol. It had manufacturing agreement with Karnataka Antibiotics Pharmaceuticals Limited for sale of Isabgol Husk based products and other veterinary products on Loan Licence basis.In 2026, the Company made manufacturing agreement with Reckit Benckiser India Ltd., for sales of Isabgol Husk based product Fybogel, Abbot HealthcatePvt Ltd., for sales of FABOLITE Karnataka Antibiotics Pharmaceuticals Ltd for sale of Husky,RadiantNutracetical Bangladesh for exports, Rhine Biogenics Pvt. Ltd for sale of Trugol SF Powder Nutragenix Healthcare Pvt Ltd. for sale of Fibapure Group of product and Appolo Pharmacy for sale of SatIsabgol etc. Company signed further manufacturing agreement with Karnataka Antibiotics Pharmaceuticals Limited for sale of Isabgol Husk based product. It focused on development of Export Markets, for Albendazole Bolus, Fibron SF Powder and Fibermate (Isabgol based formulations) to supplement the present low domestic demand situation.
Unjha Formulations SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 5,51,083 in 5 years with a gain of 2,51,083 (+83.69%)

Unjha Formulations Fundamental

Market Cap (in crs)

12.34

Face Value

10

Turnover (in lacs)

1.39

Key Metrics

Qtr Change %
56.96% Gain from 52W Low
36.8
Dividend yield 1yr %
0

Unjha Formulations Technical Analysis

Moving Averages Analysis
27.5
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
27.00
10 EMA
26.50
12 EMA
26.40
20 EMA
25.80
26 EMA
25.30
50 EMA
23.80
100 EMA
22.80
200 EMA
22.70
Delivery & Volume
Loading chart...

Day

100.00%

Week

98.40%

Month

93.70%

Delivery & Volume

27.55
Pivot
Resistance
First Resistance
28
Second Resistance
28.45
Third Resistance
28.90
Support
First Support
27.10
Second support
26.65
Third Support
26.20
Relative Strength Index
59.53
Money Flow Index
70.64
MACD
1.09
MACD Signal
1.14
Average True Range
1.44
Average Directional Index
17.12
Rate of Change (21)
2.11
Rate of Change (125)
19.78
Compare

Unjha Formulations Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
36.9%
Public
63.1%

Unjha Formulations Latest News

14 AUG 2026
14 AUG 2026
14 AUG 2026

You can easily buy Unjha Formulations Ltd shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Unjha Formulations Ltd share price is ₹29.5 and ₹17.52 as of 17/8/2026.

Please be aware that Unjha Formulations Ltd stock prices are subject to continuous fluctuations due to various factors.